Intraperitoneal contrast material combined with CT for detection of peritoneal metastases of ovarian cancer
- PMID: 9863905
Intraperitoneal contrast material combined with CT for detection of peritoneal metastases of ovarian cancer
Abstract
Objective: To determine the sensitivity and specificity of CT-peritoneography (CT-P) in detecting peritoneal carcinomatosis in primary or recurrent ovarian cancer.
Methods: Twenty-five patients were submitted to a standard abdominal CT (CT) as well as a computed tomography after intraperitoneal infusion of contrast material (CT-P). Twenty patients had ovarian masses clinically suspected to be malignant. In five patients with ovarian cancer who underwent prior debulking surgery, recurrent disease was suspected.
Results: In 21/25 patients an ovarian malignancy was histologically confirmed. During surgery peritoneal spread was found in 13 patients; only in 5 cases CT correctly suggested peritoneal metastases (sensitivity 38%). However, in 10/13 women CT-P indicated peritoneal spread, increasing the overall sensitivity from 38% to 77%. Sensitivity varied substantially according to the different abdominal areas, and was lowest in the left subphrenic space (25%). The sensitivity of CT-P was 71% and 72% in the right paracolic gutter and the pelvis, respectively. Sensitivity of CT-P was not found to be size-dependent, but was mainly related to the morphology of the lesions, with 100% sensitivity in nodular lesions, and only 21% sensitivity for flat peritoneal lesions. CT-P did not improve detection of omental metastases, and was not advantageous when ascites was present. Previous surgery reduced overall specificity from 80% to 57%.
Conclusion: CT-P greatly improved the sensitivity of CT in the preoperative detection of peritoneal spread of ovarian malignancy. However, the technique failed to detect flat peritoneal metastases, and had a low specificity in patients with a history of prior abdominal surgery.
Similar articles
-
Peritoneal carcinomatosis: preoperative CT with intraperitoneal contrast material.Radiology. 1992 Jan;182(1):133-8. doi: 10.1148/radiology.182.1.1727276. Radiology. 1992. PMID: 1727276
-
Positron emission tomography with FDG in the detection of peritoneal and retroperitoneal metastases of ovarian cancer.Gynecol Obstet Invest. 2003;55(3):130-4. doi: 10.1159/000071525. Gynecol Obstet Invest. 2003. PMID: 12865590
-
Accuracy of MDCT in the preoperative definition of Peritoneal Cancer Index (PCI) in patients with advanced ovarian cancer who underwent peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC).Abdom Imaging. 2013 Dec;38(6):1422-30. doi: 10.1007/s00261-013-0013-9. Abdom Imaging. 2013. PMID: 23744439
-
Multidetector CT of peritoneal carcinomatosis from ovarian cancer.Radiographics. 2003 May-Jun;23(3):687-701. doi: 10.1148/rg.233025105. Radiographics. 2003. PMID: 12740470 Review.
-
Multidetector computed tomography in diagnosing peritoneal metastases in ovarian carcinoma.Acta Radiol. 2021 Dec;62(12):1696-1706. doi: 10.1177/0284185120980006. Epub 2020 Dec 17. Acta Radiol. 2021. PMID: 33334121 Review.
Cited by
-
Role of [68Ga]Ga-DOTA-FAPI-04 PET/CT in the evaluation of peritoneal carcinomatosis and comparison with [18F]-FDG PET/CT.Eur J Nucl Med Mol Imaging. 2021 Jun;48(6):1944-1955. doi: 10.1007/s00259-020-05146-6. Epub 2021 Jan 7. Eur J Nucl Med Mol Imaging. 2021. PMID: 33415432
-
Visualization and quantification of intraperitoneal tumors by in vivo computed tomography using negative contrast enhancement strategy in a mouse model of ovarian cancer.Transl Oncol. 2009 May;2(2):96-106. doi: 10.1593/tlo.08199. Transl Oncol. 2009. PMID: 19412425 Free PMC article.
-
Role of primary surgery in advanced ovarian cancer.World J Surg Oncol. 2004 Oct 2;2:32. doi: 10.1186/1477-7819-2-32. World J Surg Oncol. 2004. PMID: 15461788 Free PMC article.
-
Comparison of CT and 18F-FDG pet for detecting peritoneal metastasis on the preoperative evaluation for gastric carcinoma.Korean J Radiol. 2006 Oct-Dec;7(4):249-56. doi: 10.3348/kjr.2006.7.4.249. Korean J Radiol. 2006. PMID: 17143028 Free PMC article.
-
P.R.O.P.S. - A novel Pre-Operative Predictive Score for unresectability in patients with colorectal peritoneal metastases being considered for cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).World J Surg Oncol. 2019 Aug 7;17(1):138. doi: 10.1186/s12957-019-1673-x. World J Surg Oncol. 2019. PMID: 31391066 Free PMC article.